Jonathan Jay Mazelsky bought stock once, on Jun 12, 2026
Director at DENTSPLY SIRONA Inc., and 1 other company
SEC CIK 0001556270 · Filings on SEC.gov ↗
Jonathan Jay Mazelsky's record
3 months after each buy, from the first price a copier could get.
1 buy has 3 months of prices so far. A record shows here at 3.
Companies
Every filing
11 filings since Feb 2020, newest first
DENTSPLY SIRONA Inc.
Director
Idexx Laboratories Inc /De
President and CEO
Idexx Laboratories Inc /de
President and CEO
Idexx Laboratories Inc /de
President and CEO
Idexx Laboratories Inc /de
President and CEO
Idexx Laboratories Inc /de
President and CEO
Idexx Laboratories Inc /de
President and CEO
Idexx Laboratories Inc /de
President and CEO
Idexx Laboratories Inc /de
President and CEO
Idexx Laboratories Inc /de
President and CEO
Idexx Laboratories Inc /de
President and CEO
About Jonathan Jay Mazelsky
Jonathan Jay Mazelsky is an individual corporate insider and a member of the Board of Directors of DENTSPLY SIRONA Inc. (XRAY), where recent SEC filings show he received equity awards in connection with his service as a director.( His reported insider activity includes a June 2026 grant of 10,000 shares of common stock and a separate award of 22,822 restricted stock units, both compensation-related transactions rather than open-market purchases.(
Publicly available information also identifies Mazelsky as the President and CEO of IDEXX Laboratories Inc., indicating senior executive experience in the life sciences and healthcare tools sector.( He has been reported as holding director-level interests in DENTSPLY SIRONA and as an executive at IDEXX, reflecting a career in corporate leadership and board service.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.